ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
August 2026
Nuclear Technology
July 2026
Fusion Science and Technology
Latest News
Launching into tomorrow: NRIC guides new era of research and deployment
In June 2025, the Department of Energy announced the Reactor Pilot Program, an authorization pathway that allowed reactor developers to partner with the DOE to get first-of-a-kind (FOAK) reactors built and tested. Soon after, the DOE rolled out a complementary Fuel Line Pilot Program, which aimed to fast-track fuel projects. In all, 20 projects were accepted into the new programs.
Pablo Yepes, Sharmalee Randeniya, Phillip J. Taddei, Wayne D. Newhauser
Nuclear Technology | Volume 168 | Number 3 | December 2009 | Pages 736-740
Proton Therapy | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (PART 3) / Radiation Protection | doi.org/10.13182/NT09-A9298
Articles are hosted by Taylor and Francis Online.
Monte Carlo codes are utilized for accurate dose calculations in proton radiation therapy research. While they are superior in accuracy to commonly used analytical dose calculations, they require significantly longer computation times. The aim of this work is to characterize a Monte Carlo track-repeating algorithm to increase computation speed without compromising dosimetric accuracy. The track-repeating approach reduced the CPU time required for a complete dose calculation in voxelized patient anatomy by more than two orders of magnitude, while on average reproducing the results from the traditional Monte Carlo approach within 4% dose difference and within 1-mm distance to agreement.